OncoQuest Pharmaceuticals Inc (078590) — Free Cash Flow Generation Index
OncoQuest Pharmaceuticals Inc (078590) has a Free Cash Flow Generation Index of 1.18x as of December 2025. Free cash flow of ₩621.20 Million represents 1% of operating cash flow (₩526.70 Million). Explore 078590 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
OncoQuest Pharmaceuticals Inc Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for OncoQuest Pharmaceuticals Inc across 9 annual periods. For the full cash flow conversion analysis, see OncoQuest Pharmaceuticals Inc operating cash flow efficiency.
Annual Free Cash Flow Generation for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year Free Cash Flow Generation Index for OncoQuest Pharmaceuticals Inc. Check OncoQuest Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.43x | ₩-695.22 Million | ₩485.35 Million | ₩1.18 Billion | ▼ -492.4% |
| 2024 | 0.37x | ₩1.45 Billion | ₩3.96 Billion | ₩2.51 Billion | ▼ -56.0% |
| 2023 | 0.83x | ₩9.29 Billion | ₩11.19 Billion | ₩1.90 Billion | ▼ -43.1% |
| 2020 | 1.46x | ₩11.03 Billion | ₩7.55 Billion | ₩3.48 Billion | ▼ -24.0% |
| 2018 | 1.92x | ₩2.77 Billion | ₩1.44 Billion | ₩1.33 Billion | ▲ +51.7% |
| 2017 | 1.27x | ₩6.07 Billion | ₩4.79 Billion | ₩1.28 Billion | ▼ -12.9% |
| 2016 | 1.45x | ₩5.15 Billion | ₩3.54 Billion | ₩1.61 Billion | ▼ -28.7% |
| 2015 | 2.04x | ₩5.70 Billion | ₩2.79 Billion | ₩2.91 Billion | ▼ -5.6% |
| 2014 | 2.16x | ₩2.19 Billion | ₩1.02 Billion | ₩1.18 Billion | — |